As the use of bariatric surgical procedures increases worldwide, a new post-surgical complication, hyperinsulinemic hypoglycemia
, is increasingly reported.
The goal of the Phase 2 clinical program was to assist the safety and efficacy of the ZP-Glucagon patch in comparison to the standard-of-care in reversing insulin ingested hypoglycemia
in adult subjects with Type 1 diabetes.
7 mmol/L)], particularly after meals, and symptomatic hypoglycemia
that consistently occurred between 2400 and 0230 daily [capillary glucose: 34-58 mg/dL (1.
Severe dysglycemia was defined as an episode of hyperglycemia or hypoglycemia
resulting in a visit to the emergency department or hospitalization within 30 days after the start of antibiotic treatment.
also was frequently preceded by the patient taking the wrong dose of insulin or the wrong insulin product, usually taking rapid-acting insulin instead of long-acting insulin.
However, the medications which are very effective in treating diabetes could lead to hypoglycemia
An evidenced- based protocol for managing hypoglycemia
We found that the artificial pancreas improved glucose control by 15 per cent and significantly reduced the risk of hypoglycemia
as compared with conventional insulin pump therapy," explained engineer Ahmad Haidar, first author of the study and doctoral student in Dr.
For 2 months prior to admission, she had been experiencing episodes of hypoglycemia
, and she had discontinued her oral antidiabetic drugs.
The Company's product, called the Diabetes Sentry[TM], is worn like a wristwatch and is the only non-invasive device currently on the world market for the detection of hypoglycemia
Dietary changes that occur as cognitive impairment progresses into dementia also might make cognitively impaired diabetics more susceptible to hypoglycemia
, and memory problems may make compliance difficult, especially when patients have complicated or intensive antidiabetic regimens, she added.
Respondents were least likely to ask about fasting blood glucose, HbA1c levels and history of hypoglycemia
New chapters address the growing problem of hypoglycemia
in patients with Type 2 diabetes, and the importance of nocturnal hypoglycemia
sometimes overlooked in clinical practice.
San Francisco, CA), a privately held biotechnology company developing treatments for metabolic diseases, has secured a critical patent from the United States Patent and Trademark Office for the use of very low dose glucagon, or DIO-901, in the prevention of insulin-induced hypoglycemia
in diabetes patients.
Individuals with diabetes have defects in glucose homeostatic pathways, including the counterregulatory pathways that oppose hypoglycemia
and ensure sufficient glucose is available to serve the brain's metabolic needs.